Covid-19 (Temas de Saúde Pública)
Estudo observacional mostrou que a vacina da Moderna está associada com efetividade aumentada, em comparação com a vacina da Pfizer, contra infecção sintomática por SARS-CoV-2.
13 Dez, 2021 | 11:41hComparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection – Med
Conteúdos relacionados:
Opinion | Is Moderna really better than Pfizer—or is it just a higher dose?
Comentário no Twitter
New @MedCellPress
Comparative effectiveness of the Pfizer and Moderna vaccines over time, in both the Alpha and Delta US waves, vs symptomatic infections https://t.co/RlWUXeZ2f2
consistent 8-12 % points advantage for Moderna pic.twitter.com/IwHXFIKaEp— Eric Topol (@EricTopol) December 11, 2021
Fauci afirma que versões de vacinas contra Covid-19 específicas para a variante Ômicron podem não ser necessárias.
13 Dez, 2021 | 11:39hFauci says Omicron-specific version of Covid-19 vaccines may not be necessary – STAT
Covid-19: vacinas funcionam contra a variante Ômicron? – Esta e outras questões respondidas.
13 Dez, 2021 | 11:38hCovid-19: Do vaccines work against omicron—and other questions answered – The BMJ
Opinião | Revogue-se a proibição de viagens partindo de países africanos.
13 Dez, 2021 | 11:36hRevoke the Omicron Travel Ban Against African Countries – The New York Times (alguns artigos gratuitos por mês)
Comentário no Twitter
Revoke the Omicron Travel Ban Against African Countries https://t.co/RhuHtnCYgR. Well said @SaadOmer3 this is not based in science and simply unjustifiable and needs to end now.
— Carlos del Rio (@CarlosdelRio7) December 11, 2021
Avanço das infecções por SARS-CoV-2 em indivíduos plenamente vacinados: medição, causas e impacto.
10 Dez, 2021 | 11:32h
Comentário no Twitter
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact https://t.co/dd91AkYmu4 pic.twitter.com/1ByzLeTdlh
— Nature Rev Immunol (@NatRevImmunol) December 7, 2021
Surgimento, diversidade genômica e disseminação global do SARS-CoV-2.
10 Dez, 2021 | 11:31hThe emergence, genomic diversity and global spread of SARS-CoV-2 – Nature
Editorial | Surgimento de variantes do SARS-CoV-2: atirando no mensageiro.
10 Dez, 2021 | 11:30hEmerging SARS-CoV-2 variants: shooting the messenger – The Lancet Infectious Diseases
Comentário no Twitter
"Omicron is the latest variant but is unlikely to be the last. We cannot risk disincentivising nations from alerting the world to new variants. In fact, globally, we would benefit from upscaling genomic surveillance" @TheLancetInfDis #IDTwitter #MedEd https://t.co/3Mz6WAgsKD
— Antibiotic Stewa®️x🆔 Bassam Ghanem (@ABsteward) December 9, 2021
Infodemia: um novo desafio para a saúde pública.
10 Dez, 2021 | 11:28hInfodemics: A new challenge for public health – Cell
Ver também:
What is an infodemic and how can we prevent it?
Comentário no Twitter
What pandemics and infodemics don’t have in common could help us learn how to fight them, experts suggest in a new @CellCellPress Commentary. Read more here: https://t.co/15nVCiebLI@Walter4C pic.twitter.com/7viNB9yRvR
— Cell Press (@CellPressNews) December 9, 2021
A variante Ômicron se dissemina, mas casos graves permanecem baixos na África do Sul.
10 Dez, 2021 | 11:27hOmicron spreads but severe cases remain low in South Africa – WHO Africa
Enquanto chegam dados preliminares da disseminação da variante Ômicron nos EUA, chefe do CDC sugere que a variante é “leve”.
10 Dez, 2021 | 11:26hCDC chief says Omicron is ‘mild’ as early data comes in on US spread of variant – The Guardian